Effect of intensive dialysis and Hb correction in ESRD patient
Not Applicable
- Conditions
- End Stage Renal Disease.Chronic kidney disease, stage 5
- Registration Number
- IRCT20180212038705N1
- Lead Sponsor
- Ahvaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
SPAP> 35 mm Hg
Cr 2-6 mg/dL
age >18
Hemodialysis patients with ESRD
Exclusion Criteria
Acute or c?ronic PET and COPD
Severe valvular disease
Patients with recent MI
Acute bleeding
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method PAP. Timepoint: Before and after hemodialysis. Method of measurement: Chest doppler echocardiography.;LV function. Timepoint: Before and after hemodialysis. Method of measurement: echocardiography.
- Secondary Outcome Measures
Name Time Method